RE-1

product on market Capsule Loomis Enzymes Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Garlic and citrus bioflavonoids have moderate evidence for supporting cardiovascular and immune health. The proprietary plant enzyme blend is intended to aid digestion, though specific clinical data for this blend is limited. Overall, these ingredients are generally well-tolerated with a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for RE-1
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
45
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

532 mg
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
Proprietary Plant Enzyme Blend
389 mg

Other Ingredients

Capsule
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions for use: Take 2 capsules, 2 times daily at anytime or as directed.

Warnings & Precautions

Keep out of reach of children

Note: Consult your physician before using this product if you are pregnant, nursing, taking medication, or have a medical condition.

Do not use if inner or outer seal is broken, torn, or missing.

Additional Information

To ensure freshness and potency, keep bottle tightly closed and store in a cool, dry place.

I-64978-5

Metadata

Product Details

UPC / SKU6 97706 05050 9
DSLD Entry Date2018-05-24
Product TypeOther Combinations
FormCapsule
DSLD ID177505
Data Updated2026-04-11
Research

Research Evidence

142
Research Sources
53
Avg Quality
70
Meta Analysis
56
Systematic Review
12
Rct
2
Regulatory Source
1
Openfda Safety
B Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients
Systematic Review The Cochrane database of systematic reviews 2012 PubMed DOI
B Garlic supplementation for the treatment of chronic liver disease: a meta-analysis of randomized controlled trials
Meta Analysis African health sciences 2023 PubMed DOI
B Consumption of large amounts of Allium vegetables reduces risk for gastric cancer in a meta-analysis
Meta Analysis Gastroenterology 2011 PubMed DOI
B Garlic for the common cold
Systematic Review The Cochrane database of systematic reviews 2014 PubMed DOI
B Effects of Garlic Supplementation on Cardiovascular Risk Factors in Adults: A Comprehensive Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta Analysis Nutrition reviews 2026 PubMed DOI
B Effects of seasoning on the formation of heterocyclic amines and polycyclic aromatic hydrocarbons in meats: A meta-analysis
Meta Analysis Comprehensive reviews in food science and food safety 2021 PubMed DOI
B A Systematic Review and Meta-Analysis of Ayurvedic Herbal Preparations for Hypercholesterolemia
Meta Analysis Medicina (Kaunas, Lithuania) 2021 PubMed DOI
B Garlic: A systematic review of the effects on cardiovascular diseases
Systematic Review Critical reviews in food science and nutrition 2023 PubMed DOI
B Garlic intake lowers fasting blood glucose: meta-analysis of randomized controlled trials
Meta Analysis Asia Pacific journal of clinical nutrition 2015 PubMed DOI
B Garlic for the common cold
Systematic Review The Cochrane database of systematic reviews 2012 PubMed DOI
View all evidence for Garlic →
Compare

Similar Products

View all Garlic products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.